Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
Multiracial LGBTQ people gesturing to be fine with a thumbs-up.
The guideline will provide healthcare interventions for trans and gender-diverse people who suffered interpersonal violence based on their needs.

WHO to Develop A Guideline for Trans and Gender-Diverse People’s Health

New guideline will provide interventions to increase access and equitable utilization of quality health services

World Health Organization
Published:Dec 18, 2023
|2 min read
Register for free to listen to this article
Listen with Speechify
0:00
5:00

The WHO's Departments of Gender, Rights and Equity - Diversity, Equity and Inclusion (GRE-DEI), Global HIV, Hepatitis and STIs Programmes (HHS), and Sexual and Reproductive Health and Research (SRH) are developing a guideline on the health of trans and gender-diverse people.

This new guideline will provide evidence and implementation guidance on health sector interventions aimed at increasing access and utilization of quality and respectful health services by trans and gender-diverse people. The guideline will focus on five areas: 

  • Provision of gender-affirming care, including hormones.

  • Health workers education and training for the provision of gender-inclusive care.

  • Provision of health care for trans and gender-diverse people who suffered interpersonal violence based on their needs.

  • Health policies that support gender-inclusive care, and legal recognition of self-determined gender identity. 

Following the WHO guidance, a guideline development group (GDG) will be composed of members from all the WHO regions acting in their individual capacity (not representing any organization with which they are affiliated). The members of the GDG are not commissioned and do not receive any financial compensation. Members of the GDG for this guideline were chosen by WHO technical staff among researchers with relevant technical expertise, end-users (program managers and health workers), and representatives of trans and gender-diverse community organizations.

The GDG will meet from 19 to 21 February 2024 at the WHO’s headquarters in Geneva to:

  1. examine the grading of recommendations assessment, development, and evaluation (GRADE) evidence profiles or other assessments of the quality of the evidence used to inform the recommendations on the above-mentioned focus areas,

  2. interpret the evidence, with explicit consideration of the overall balance of benefits and harms,

  3. formulate recommendations, taking into account benefits, harms, values and preferences, feasibility, equity, acceptability, resource requirements, and other factors, as appropriate, and

  4. suggest implementation considerations and highlight research gaps for the guidelines.

- This press release was originally published on the World Health Organization website